Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sagent Pharmaceuticals is a specialty pharmaceutical company focused on the development, manufacturing, and sourcing of generic injectable products for the hospital and clinical markets. The company offers a diverse portfolio of anti-infectives, oncology treatments, and critical care medicines, utilizing a global network of manufacturing partners to ensure supply chain resilience. A hallmark of the company is its "PreventIV Measures" packaging and labeling system, which uses distinct colors and clear labeling to help healthcare professionals reduce medication errors. In 2016, Sagent was acquired by Nichi-Iko Pharmaceutical, a leading Japanese generic drug manufacturer, for approximately $736 million. Today, Sagent operates as a key subsidiary of Nichi-Iko, maintaining significant manufacturing operations in the United States and China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sagent Technologies.